These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11150743)

  • 1. In vivo models of myocardial ischemia and reperfusion injury: application to drug discovery and evaluation.
    Black SC
    J Pharmacol Toxicol Methods; 2000; 43(2):153-67. PubMed ID: 11150743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
    Gumina RJ; Daemmgen J; Gross GJ
    Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for studying experimental myocardial ischemic and reperfusion injury.
    Black SC; Rodger IW
    J Pharmacol Toxicol Methods; 1996 Aug; 35(4):179-90. PubMed ID: 8823664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure.
    Morris K
    Expert Opin Ther Targets; 2002 Jun; 6(3):291-8. PubMed ID: 12223070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Na+/H+ exchange inhibitors for ischemic diseases].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):363-70. PubMed ID: 11778453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger.
    Avkiran M
    J Card Surg; 2003; 18 Suppl 1():3-12. PubMed ID: 12691374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury.
    Levitsky J; Gurell D; Frishman WH
    J Clin Pharmacol; 1998 Oct; 38(10):887-97. PubMed ID: 9807968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury.
    Karmazyn M
    Keio J Med; 1998 Jun; 47(2):65-72. PubMed ID: 9659815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide.
    Karmazyn M
    Ann N Y Acad Sci; 1999 Jun; 874():326-34. PubMed ID: 10415544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).
    Chakrabarti S; Hoque AN; Karmazyn M
    J Mol Cell Cardiol; 1997 Nov; 29(11):3169-74. PubMed ID: 9405190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.
    Aihara K; Hisa H; Sato T; Yoneyama F; Sasamori J; Yamaguchi F; Yoneyama S; Mizuno Y; Takahashi A; Nagai A; Kimura T; Kogi K; Satoh S
    Eur J Pharmacol; 2000 Sep; 404(1-2):221-9. PubMed ID: 10980282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of [5-(2-methoxy-5-fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32560), a novel sodium/hydrogen exchanger-1 inhibitor, on myocardial infarct size and ventricular arrhythmias in a rat model of ischemia/reperfusion heart injury.
    Park JW; Roh HY; Jung IS; Yun YP; Yi KY; Yoo SE; Kwon SH; Chung HJ; Shin HS
    J Pharmacol Sci; 2005 Aug; 98(4):439-49. PubMed ID: 16082174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of the sodium/hydrogen exchanger after prolonged regional ischemia improves contractility on reperfusion independent of myocardial viability.
    Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; Spinale FG
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1489-97. PubMed ID: 14666024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
    Maczewski M; Beresewicz A
    Eur J Pharmacol; 2003 Feb; 461(2-3):139-47. PubMed ID: 12586209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs.
    Gumina RJ; Buerger E; Eickmeier C; Moore J; Daemmgen J; Gross GJ
    Circulation; 1999 Dec 21-28; 100(25):2519-26; discussion 2469-72. PubMed ID: 10604890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
    Lee BH; Yi KY; Lee S; Lee S; Yoo SE
    Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.
    Kloner RA; Przyklenk K; Whittaker P
    Circulation; 1989 Nov; 80(5):1115-27. PubMed ID: 2553296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.